What is the catalog number for Sarcosine-13C3, 15N?

The catalog number for Sarcosine-13C3, 15N is CS-T-103783.

What sizes are available for Sarcosine-13C3, 15N?

Sarcosine-13C3, 15N is available in the following size(s): 1 Each.

Is Sarcosine-13C3, 15N in stock?

Sarcosine-13C3, 15N is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Sarcosine-13C3, 15N?

The safety data sheet for Sarcosine-13C3, 15N is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-T-103783.

Sarcosine-13C3, 15N

Sarcosine-13C3, 15N is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Sarcosine. The product is supplied by Clearsynth under CAT No. CS-T-103783. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

Sarcosine-13C3, 15N is an isotope labelled compound of Sarcosine (S140500) . Sarcosine is a typeÃ 1 glycine transporter inhibitor and a glycine agonist that may be useful for treating schizophrenia. Also, used in the study of the potential therapeutic efficacy of glycine transporter 1 inhibitors in the treatment of central nervous system disorders in human system.

Synonyms

Sarcosine-13C3, 15N

Molecular Formula

13 C 3 H 715 NO 2

Molecular Weight

93.06

Additionnal Information

Sarcosine-13C3, 15N is supplied with detailed characterization data compliant with regulatory guideline. Sarcosine-13C3, 15N can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Sarcosine.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

Sarcosine-13C3, 15N is an isotope labelled compound of Sarcosine (S140500) . Sarcosine is a typeÃ 1 glycine transporter inhibitor and a glycine agonist that may be useful for treating schizophrenia. Also, used in the study of the potential therapeutic efficacy of glycine transporter 1 inhibitors in the treatment of central nervous system disorders in human system.